AR029377A1 - PROTEINAL TOXINS, NUCLEIC ACID, PROCEDURE FOR PREPARATION, POLYPEPTIDE, ITS PREPARATION PROCEDURE, ANTIBODY, ITS PROCEDURE FOR OBTAINING, MEDICATION, PROCEDURE FOR OBTAINING, DIAGNOSTIC AGENT, ITS PROCEDURE FOR PREPARATION FOR PREPARATION - Google Patents

PROTEINAL TOXINS, NUCLEIC ACID, PROCEDURE FOR PREPARATION, POLYPEPTIDE, ITS PREPARATION PROCEDURE, ANTIBODY, ITS PROCEDURE FOR OBTAINING, MEDICATION, PROCEDURE FOR OBTAINING, DIAGNOSTIC AGENT, ITS PROCEDURE FOR PREPARATION FOR PREPARATION

Info

Publication number
AR029377A1
AR029377A1 ARP000103393A ARP000103393A AR029377A1 AR 029377 A1 AR029377 A1 AR 029377A1 AR P000103393 A ARP000103393 A AR P000103393A AR P000103393 A ARP000103393 A AR P000103393A AR 029377 A1 AR029377 A1 AR 029377A1
Authority
AR
Argentina
Prior art keywords
procedure
preparation
protein toxins
obtaining
nucleic acids
Prior art date
Application number
ARP000103393A
Other languages
Spanish (es)
Original Assignee
Aventis Res & Techonologies Gm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Res & Techonologies Gm filed Critical Aventis Res & Techonologies Gm
Publication of AR029377A1 publication Critical patent/AR029377A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Fodder In General (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Toxinas proteicas son polipéptidos, que poseen propiedades antimicoticas y/o antifungicas. Antimicoticos selectivos son de gran importancia, ya que se ha incrementado fuertemente las infecciones causadas por hongos y levaduras en el ser humano en los ultimos tiempos y que asimismo provoca siempre contaminaciones indeseables en comidas y sustancias alimenticias. Se describe toxinas proteicas de levadura, ácidos nucleicos que codifican para estas toxinas proteicas, procedimiento para su preparacion de toxinas proteicas y procedimiento para la preparacion de ácidos nucleicos codificados, anticuerpos que están dirigidos contra las toxinas proteicas, medicamentos y agentes dei diagnostico, que contienen las toxinas proteicas, ácidos nucleicos y anticuerpos de la presente, así como el empleo de toxinas proteicas o ácidos nucleicos para identificar interactores funcionales, para la identificacion de variantes, para combatir levaduras perjudiciales, para preparar medicamentos y agentes de diagnostico y para preparar plantas y células de plantas transgénicas.Protein toxins are polypeptides, which possess antifungal and / or antifungal properties. Selective antifungal agents are of great importance, since the infections caused by fungi and yeasts in humans have increased sharply in recent times and that also always causes undesirable contamination in foods and food substances. It describes protein toxins of yeast, nucleic acids that code for these protein toxins, procedure for their preparation of protein toxins and procedure for the preparation of encoded nucleic acids, antibodies that are directed against protein toxins, medications and diagnostic agents, which contain the protein toxins, nucleic acids and antibodies of the present, as well as the use of protein toxins or nucleic acids to identify functional interactors, for the identification of variants, to combat harmful yeasts, to prepare medicines and diagnostic agents and to prepare plants and transgenic plant cells.

ARP000103393A 1999-07-05 2000-07-03 PROTEINAL TOXINS, NUCLEIC ACID, PROCEDURE FOR PREPARATION, POLYPEPTIDE, ITS PREPARATION PROCEDURE, ANTIBODY, ITS PROCEDURE FOR OBTAINING, MEDICATION, PROCEDURE FOR OBTAINING, DIAGNOSTIC AGENT, ITS PROCEDURE FOR PREPARATION FOR PREPARATION AR029377A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19930959A DE19930959A1 (en) 1999-07-05 1999-07-05 New antimycotics and fungicides, process for their production and use

Publications (1)

Publication Number Publication Date
AR029377A1 true AR029377A1 (en) 2003-06-25

Family

ID=7913696

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000103393A AR029377A1 (en) 1999-07-05 2000-07-03 PROTEINAL TOXINS, NUCLEIC ACID, PROCEDURE FOR PREPARATION, POLYPEPTIDE, ITS PREPARATION PROCEDURE, ANTIBODY, ITS PROCEDURE FOR OBTAINING, MEDICATION, PROCEDURE FOR OBTAINING, DIAGNOSTIC AGENT, ITS PROCEDURE FOR PREPARATION FOR PREPARATION

Country Status (17)

Country Link
EP (1) EP1196608A2 (en)
JP (1) JP2003504030A (en)
KR (1) KR20020059581A (en)
CN (1) CN1361825A (en)
AR (1) AR029377A1 (en)
AU (1) AU5969400A (en)
BR (1) BR0012172A (en)
CA (1) CA2372935A1 (en)
CZ (1) CZ200249A3 (en)
DE (1) DE19930959A1 (en)
HU (1) HUP0201690A3 (en)
IL (1) IL147252A0 (en)
NO (1) NO20020003L (en)
PL (1) PL364765A1 (en)
SK (1) SK122002A3 (en)
TR (1) TR200200097T2 (en)
WO (1) WO2001002587A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5467251B2 (en) * 2008-08-12 2014-04-09 株式会社ソフィ Method for quantifying β-1,3-1,6-glucan
PT105331A (en) * 2010-10-12 2012-04-12 Cev Biotecnologia Das Plantas S A PRESERVATIVE FOOD
CN107164248B (en) * 2017-03-16 2020-11-10 中国水产科学研究院南海水产研究所 Yeast DD12-7 strain and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97020A (en) * 1990-01-30 2000-12-06 Mogen Int Recombinant polynucleotides comprising a chitinase gene and a glucanase gene
GB9115669D0 (en) * 1991-07-19 1991-09-04 Sandoz Ltd Improvements in or relating to organic compounds
US5783183A (en) * 1993-03-03 1998-07-21 Gist-Brocades, B.V. Cloning of the zymocin gene and use of zymocin in beverages

Also Published As

Publication number Publication date
SK122002A3 (en) 2002-05-09
CA2372935A1 (en) 2001-01-11
DE19930959A1 (en) 2001-01-25
AU5969400A (en) 2001-01-22
NO20020003D0 (en) 2002-01-02
WO2001002587A3 (en) 2002-02-07
NO20020003L (en) 2002-02-28
BR0012172A (en) 2002-03-05
HUP0201690A3 (en) 2004-10-28
EP1196608A2 (en) 2002-04-17
KR20020059581A (en) 2002-07-13
WO2001002587A2 (en) 2001-01-11
JP2003504030A (en) 2003-02-04
IL147252A0 (en) 2002-08-14
TR200200097T2 (en) 2002-05-21
HUP0201690A2 (en) 2002-09-28
PL364765A1 (en) 2004-12-13
CZ200249A3 (en) 2002-04-17
CN1361825A (en) 2002-07-31

Similar Documents

Publication Publication Date Title
Waller Anthelmintic resistance
AR082240A2 (en) METHOD FOR OBTAINING PLANTS WITH MODIFIED GROWTH CHARACTERISTICS, A CONSTRUCTION; A CELL GUEST; A TRANSGENIC PLANT AND USES
NO2017027I1 (en) efmoroctocog alfa or a bio-equivalent drug in accordance with Article 10 (4) of Directive 2001/83 / EC, as protected by the basic patent.
AR053052A1 (en) COMPOSITIONS THAT INCLUDE TWO COMPONENTS AND THAT ARE USEFUL AS FOOD FOR PETS
Gutiérrez et al. Nanotechnology and food industry
CL2021002744A1 (en) Modified pesticide proteins and methods to control plant pests. (request divisional 201901544)
AR107600A1 (en) COMPOSITIONS THAT INCLUDE Cry PROTEIN AND METHODS TO CONTROL PLANT PESTS
WO2015021354A3 (en) Pesticidal toxin active against coleopteran and/or hemipteran insects
WO2006137069A3 (en) Balanites aegyptiaca saponins and uses thereof
BR112017007927A2 (en) enhanced activity spectrum insecticidal polypeptides and their uses
UY36057A (en) ACTIVE PESTICIDE PROTEINS AGAINST COLEOPTER INSECTS, RECOMBINATING NUCLEIC ACID, POLYPEPTIDE, COMPOSITION, METHOD FOR CONTROLLING INSECTS, PLANTS AND THEIR PARTS
BRPI0512743A (en) capsules, dispensing system, food product, and process for preparing the capsules
CL2019001128A1 (en) Insecticidal proteins
CO2019008595A2 (en) Pesticidal toxin proteins active against lepidopteran insects
BRPI0616492B8 (en) uses of a guar protein extract
Neri-Castro et al. Neotropical Rattlesnake (Crotalus simus) venom pharmacokinetics in lymph and blood using an ovine model
EP4275751A3 (en) Improved naglu fusion protein formulation
AR029377A1 (en) PROTEINAL TOXINS, NUCLEIC ACID, PROCEDURE FOR PREPARATION, POLYPEPTIDE, ITS PREPARATION PROCEDURE, ANTIBODY, ITS PROCEDURE FOR OBTAINING, MEDICATION, PROCEDURE FOR OBTAINING, DIAGNOSTIC AGENT, ITS PROCEDURE FOR PREPARATION FOR PREPARATION
AR108284A1 (en) INSECTICIDE COMBINATIONS OF POLYPEPTIDES THAT HAVE ENHANCED SPECTRUM OF ACTIVITY AND USES OF THESE
BR9408415A (en) Antimicrobial protein antimicrobial agent dna encoding biological system plant and process to fight fungi and bacteria
BRPI0515936A (en) activated globular protein and its use in edible compositions
Lobo et al. Host-defense peptides as new generation phytosanitaries: Low toxicity and low induction of antimicrobial resistance
CN104211804A (en) Preparation and application of anti-staphylococcus aureus polyclonal antibody
DE69333781D1 (en) BIOZIDE CHITIN BINDING PROTEINS
Coelho et al. Neglected venomous animals and toxins: underrated biotechnological tools in drug development